Kinematic gait parameters for older adults with Parkinson's disease during street crossing simulation.

Kinematic gait parameters for older adults with Parkinson's disease during street crossing simulation. Hum Mov Sci. 2020 Apr;70:102599 Authors: Amaral-Felipe KMD, Yamada PA, Abreu DCC, Freire Júnior RC, Stroppa-Marques AEZ, Faganello-Navega FR Abstract Safe street crossing is important for older adults' social inclusion. We assessed gait kinematic adaptation under different simulated street crossing conditions in older adults with Parkinson's disease (PD) and made comparisons with older adults without PD to understand how PD interferes in outdoor task performance, helping in the development of strategies to reduce road traffic accident risk. In 20 older adults without PD (control group - CG) and 20 with PD (GPD), we assessed usual gait (C1), gait during street crossing simulation (C2), and gait during reduced-time street crossing simulation (C3). Velocity, step length, and step, swing, stance, and double support time were analyzed. Spatiotemporal differences in gait between groups and conditions were analyzed. The GPD walked 16% slower in C1 and 12% slower in C2 and C3 than the CG. GPD also took 11% shorter steps in C1 and 9.5% shorter steps in C2. The double support time was 8.5% greater in C1. In intragroup comparisons, there were significant differences in all gait conditions. The CG showed increased velocity (C2 15% > C1; C3 13% > C2; C3 26% > C1), step length (C2 8% > C1; C3 5% >&nbs...
Source: Human Movement Science - Category: Neurology Authors: Tags: Hum Mov Sci Source Type: research

Related Links:

Authors: Shimada H, Shimada Y Abstract An 86-year-old man, who had undergone a lumboperitoneal shunt for idiopathic normal pressure hydrocephalus (iNPH) implanted 4 years earlier showed progressive parkinsonism for the past year. His clinical symptoms, including resting tremor and rapid eye movement sleep behavior disorder, responsiveness to levodopa, and abnormal findings on 123I-MIBG myocardial scintigraphy and dopamine transporter imaging, indicated that his pathological background of parkinsonism included concomitant synucleinopathy, such as Parkinson's disease or dementia with Lewy bodies, in addition to iNPH....
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research
Publication date: Available online 29 May 2020Source: Neurología (English Edition)Author(s): F. Valldeoriola, F. Grandas, J.M. Arbelo, M. Blázquez Estrada, M. Calopa Garriga, V.M. Campos-Arillo, P.J. Garcia Ruiz, J.C. Gómez Esteban, C. Leiva Santana, J.C. Martínez Castrillo, P. Mir, A. Salvador Aliaga, F. Vivancos Matellano, R.M. Yáñez Baña
Source: Neurologia - Category: Neurology Source Type: research
Conclusions: The current study indicates that TG infection could improve the cataleptic, asymmetric, nociceptive and behaviors; the level of striatal dopamine release; BDNF levels; TAC; and MDA in PD rats. PMID: 32461971 [PubMed - in process]
Source: Biomed Res - Category: Research Authors: Tags: Biomed Res Int Source Type: research
Effects of Cardiac Sympathetic Neurodegeneration and PPARγ Activation on Rhesus Macaque Whole Blood miRNA and mRNA Expression Profiles. Biomed Res Int. 2020;2020:9426204 Authors: Metzger JM, Lopez MS, Schmidt JK, Murphy ME, Vemuganti R, Emborg ME Abstract Degeneration of sympathetic innervation of the heart occurs in numerous diseases, including diabetes, idiopathic REM sleep disorder, and Parkinson's disease (PD). In PD, cardiac sympathetic denervation occurs in 80-90% of patients and can begin before the onset of motor symptoms. Today, there are no disease-modifying therapies for cardiac sympa...
Source: Biomed Res - Category: Research Authors: Tags: Biomed Res Int Source Type: research
PARKINSON'S disease predominantly affects a certain region in the brain. As the condition gradually becomes apparent, what's the one change in bowel habits that may lead to an earlier diagnosis?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Publication date: Available online 28 May 2020Source: Stem Cell ReportsAuthor(s): Akihiro Yamaguchi, Kei-ichi Ishikawa, Tsuyoshi Inoshita, Kahori Shiba-Fukushima, Shinji Saiki, Taku Hatano, Akio Mori, Yutaka Oji, Ayami Okuzumi, Yuanzhe Li, Manabu Funayama, Yuzuru Imai, Nobutaka Hattori, Wado Akamatsu
Source: Stem Cell Reports - Category: Stem Cells Source Type: research
Publication date: September 2020Source: Neurochemistry International, Volume 138Author(s): Francesco Dernie
Source: Neurochemistry International - Category: Neuroscience Source Type: research
Although nilotinib is safe and tolerable in patients with moderate or advanced Parkinson's disease, it may not affect the disease's symptoms,   according to investigators.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Condition:   Parkinson Disease Intervention:   Other: Cycling deep brain stimulation Sponsor:   University of Sao Paulo General Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
The authors regret not having included the name of Camilla Zamfolini Hallal as a co-author of the referred article at the appropriate time. However, in view of the important contributions of the co-author to the article, we request this misunderstanding to...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
More News: Accidents | Neurology | Parkinson's Disease | Science